Malcolm Salter's most recent trade in C4 Therapeutics Inc was a trade of 32,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C4 Therapeutics Inc | Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 31.58 per share. | 04 Jan 2022 | 428 | 11,380 | - | 31.6 | 13,516 | Common Stock |
| C4 Therapeutics Inc | Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 17 Dec 2021 | 755 | 10,952 | - | 30.3 | 22,839 | Common Stock |
| C4 Therapeutics Inc | Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 40.11 per share. | 19 Nov 2021 | 755 | 11,707 | - | 40.1 | 30,283 | Common Stock |
| C4 Therapeutics Inc | Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 44.94 per share. | 15 Oct 2021 | 755 | 12,462 | - | 44.9 | 33,930 | Common Stock |
| C4 Therapeutics Inc | Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 44.99 per share. | 04 Oct 2021 | 300 | 13,217 | - | 45.0 | 13,497 | Common Stock |
| C4 Therapeutics Inc | Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 49.89 per share. | 17 Sep 2021 | 755 | 12,917 | - | 49.9 | 37,667 | Common Stock |
| C4 Therapeutics Inc | Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 40.73 per share. | 20 Aug 2021 | 755 | 13,672 | - | 40.7 | 30,751 | Common Stock |